Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'
Key facts
- Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'
- The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
- Source: PR Times
- Date: April 13, 2026
Direct answer
The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
- Citation
- Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project' (April 13, 2026), PR Times
- Source
- PR Times
- Date
- April 13, 2026
The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
📋 Article Processing Timeline
- 📰 Published: April 13, 2026 at 14:00
- 🔍 Collected: April 13, 2026 at 14:31 (31 min after Published)
- 🤖 AI Analyzed: April 19, 2026 at 20:54 (150h 22m after Collected)
FAQ
When was the Osaka International Cancer Institute founded, and what is its primary specialization?
The institute was founded in 1959 and is a specialized medical institution dedicated exclusively to cancer treatment and research.
Who is Dr. Kei Kunimasa and what role does he hold in the research project mentioned?
Dr. Kei Kunimasa serves as the Deputy Director of Respiratory Medicine and leads the research project selected for AMED’s FY2026 Innovative Cancer Medical Practical Application Research Project.
What specific AMED program selected the research project led by Dr. Kei Kunimasa, and in which fiscal year?
The research project was selected by AMED under its FY2026 Innovative Cancer Medical Practical Application Research Project program, aiming to translate advanced cancer therapies into clinical practice.
How does the Osaka International Cancer Institute describe its philosophy toward patient care and medical development?
The institute’s philosophy emphasizes providing and developing advanced cancer medical care from the patient’s perspective, prioritizing high-quality treatment, innovative research, and human resource development.
In what capacity does the Osaka International Cancer Institute serve the Osaka region, according to the article?
The institute acts as a prefectural designated cancer care hospital, supporting cancer medical care throughout Osaka and contributing broadly to society by maintaining close, patient‑family‑centered clinical practice.